Abstract
Persistent virus infections are discussed from the virus point of view in terms of the bodily sites in which the infection persists. Glands and body surfaces are thought to be significant because they give the virus protection at the topographical level from immune forces, and because they are appropriate sites for the shedding of virus to the exterior. Germ cells are relevant sites because infection can thus be transmitted vertically from generation to generation in the host. The central nervous system, however, is generally a 'dead end' from which there is no shedding to the exterior. Persistance in blood may be relevant when continued arthropod transmission becomes possible. Most persistent viruses infect lymphoreticular tissues, and this is interpreted by suggesting that it results in an impaired immune response to the infecting virus, which in turn favours persistence. It is suggested that the biological function of virus transformation and the integration of viral into host cell DNA is that it enables the infection to persist in the host and undergo reactivation. Papovaviruses, adenoviruses and oncornaviruses are considered from this point of view.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armstrong J. A., Evans A. S., Rao N., Ho M. Viral infections in renal transplant recipients. Infect Immun. 1976 Oct;14(4):970–975. doi: 10.1128/iai.14.4.970-975.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Black F. L., Hierholzer W. J., Pinheiro F., Evans A. S., Woodall J. P., Opton E. M., Emmons J. E., West B. S., Edsall G., Downs W. G. Evidence for persistence of infectious agents in isolated human populations. Am J Epidemiol. 1974 Sep;100(3):230–250. doi: 10.1093/oxfordjournals.aje.a112032. [DOI] [PubMed] [Google Scholar]
- Flower A. J., Banatvala J. E., Chrystie I. L. BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br Med J. 1977 Jul 23;2(6081):220–223. doi: 10.1136/bmj.2.6081.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krech U., Jung M., Price P. C., Thiel G., Sege D., Reutter F. Virus infections in renal transplant recipients. Z Immunitatsforsch Exp Klin Immunol. 1975 Feb;148(4):341–355. [PubMed] [Google Scholar]
- Lee A. K., Eisinger M. Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens. Clin Exp Immunol. 1976 Dec;26(3):419–424. [PMC free article] [PubMed] [Google Scholar]
- Mims C. A. The meaning of persistent infections in nature. Bull World Health Organ. 1975;52(4-6):747–751. [PMC free article] [PubMed] [Google Scholar]
- Nagington J. Reactivation of hepatitis b after transplantation operations. Lancet. 1977 Mar 12;1(8011):558–560. doi: 10.1016/s0140-6736(77)91995-x. [DOI] [PubMed] [Google Scholar]
- Spencer E. S., Andersen H. K. Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J. 1970 Aug 1;3(5717):251–254. doi: 10.1136/bmj.3.5717.251. [DOI] [PMC free article] [PubMed] [Google Scholar]